Announced Tue, 19 May · 09:59 IST

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Niraj Shah

Creeping Acquisition Near ThresholdOwnership Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

—1-day move

₹256.40

prior close

₹243.60

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0+0.0+0.0—-14.2-18.5-14.5-10.2-13.4-20.0-21.2-26.3—

Up moveDown movePending

AI summary

Niraj Rajnikant Shah, a non-promoter investor based in Mumbai, has acquired 5,47,000 shares of Speciality Medicines Ltd through open market purchases. The acquisition took place between March 30, 2026 and May 14, 2026, taking his holding from 0% to 6.22% of the company's total share capital. The total equity capital of the company stands at Rs. 8.78 crore divided into 87,85,796 shares of Rs. 10 each. This disclosure is required under SEBI SAST regulations because crossing the 5% shareholding threshold triggers mandatory disclosure to stock exchanges.

Likely market impact

The acquisition of a 6.22% stake by a non-promoter in the open market may indicate bullish sentiment from a significant investor, though this holding is still well below the 25% threshold that would trigger an open offer obligation under SAST regulations.